Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

11.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.9K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Blood Transfusion01:15

Blood Transfusion

2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

492
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
492
Standard Precaution01:26

Standard Precaution

2.8K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the End.

Pathogens (Basel, Switzerland)·2026
Same author

Commentary: The Infected Blood Inquiry in the United Kingdom-Let the Dust Settle.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways.

Vox sanguinis·2024
Same author

Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape.

Vox sanguinis·2024
Same author

A Sociology of Plasma Proteins - A Technocrat's Perspective.

International journal of social determinants of health and health services·2024
Same author

Generating pathways to domestically sourced plasma-derived medicinal products: Report from a workshop by the International Plasma and Fractionation Association and the Working Party on Global Blood Safety of the International Society of Blood Transfusion.

Vox sanguinis·2024

Related Experiment Video

Updated: Jan 16, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.5K

Pathogen Safety Issues Around the "Blood Scandals" 1995-2024-A Perspective Built on Experience.

Albert Farrugia1

  • 1Medical School, The University of Western Australia, 35 Stirling Highway, Crawley, Perth, WA 6009, Australia.

Pathogens (Basel, Switzerland)
|September 27, 2025
PubMed
Summary

Public inquiries into plasma derivative safety have highlighted issues and assigned responsibility. These reviews emphasize enhanced blood safety, precautionism, transparency, and informed consent for patients.

Keywords:
HCVHIVblood screeningpathogen safetyviral inactivation

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.1K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

Related Experiment Videos

Last Updated: Jan 16, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.5K
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.1K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

Area of Science:

  • Biomedical Science
  • Public Health Policy
  • Medical Ethics

Background:

  • Over the past 30 years, public inquiries have investigated viral safety issues concerning plasma derivatives.
  • These inquiries were prompted by infections in recipients of plasma products and aimed to determine accountability.
  • The recent UK Infected Blood Inquiry (2018-2022) has issued conclusions on responsibility allocation.

Purpose of the Study:

  • To review the findings and implications of public inquiries into plasma derivative safety.
  • To analyze the allocation of responsibility for past events involving plasma derivatives.
  • To discuss the benefits of these inquiries, including advancements in blood safety and patient care principles.

Main Methods:

  • Analysis of published inquiry reports.
  • Review of peer-reviewed literature and government agency policies.
  • Inclusion of author's perspective as a plasma fractionation scientist and product recipient.

Main Results:

  • Identification of parties responsible for historical plasma derivative safety events.
  • Heightened commitment to blood safety by policymakers.
  • Establishment of precautionism as a key safety principle.

Conclusions:

  • Public inquiries have significantly improved blood safety standards and practices.
  • Transparency and informed consent are crucial for patient management in healthcare.
  • The scientific and ethical considerations surrounding plasma derivatives continue to evolve.